Navigation Links
BiOptix continues support of Colorado-based research institutions
Date:6/15/2012

BOULDER, Colo., June 15, 2012 /PRNewswire/ -- BiOptix, a Colorado-based firm, announces completion of a successful week of research shows in Colorado's Biotech Corridor.

BiOptix today announced support of events this week at National Jewish Health, the University of Colorado Denver-Anschutz Medical Campus and at the University of Colorado, Boulder.  These events brought Colorado-based researchers together with representatives of dozens of global life science research suppliers, and are a critical link in the research supply and innovation chain.  The strength and participation at these events highlight the significant research activities that exist in Colorado, and BiOptix, as a Boulder, Colorado-based company is proud to support the continued development and expansion of these efforts. 

Supporting Colorado's Growing Biotech Corridor—and our hometown of Boulder.     

Colorado's growing biotech corridor is concentrated in the Denver-Boulder metropolitan areas allowing BiOptix strategic access to these markets.  "After completing a successful show at the University of California San Francisco, last week, we are excited to turn our attention toward our home market of Colorado for this series of events," noted Ken Wilczek, Vice President of Sales & Marketing for BiOptix.  "We are grateful to have the support of our colleagues in Denver and especially in our hometown of Boulder. Colorado represents a significant opportunity to us as a supplier, not to mention what Colorado means to the global research community—it is awesome to be here."

BiOptix Events

So far in 2012, BiOptix has participated in 8 nation-wide life science industry events and has showcased a novel and patented ultra-sensitive biosensor platform known as Enhanced Surface Plasmon Resonance, or ESPR. Unlike traditional Surface Plasmon Resonance, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.  BiOptix anticipates more than 30 customer facing events in 2012, with additional planned in 2013.

About BiOptix

BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance.  BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com


'/>"/>
SOURCE BiOptix Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Profil Institute Continues to Publish New Findings in Metabolic Research
2. AMPAC Fine Chemicals Continues to Invest in Quality Systems
3. UV Flu Technologies Continues Aggressive Program to Pay off Convertible Debt
4. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
5. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
6. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
7. Fluke Biomedical training center goes global: adds multi-language support
8. MDA Supports Development of Dissociative Glucocorticoid for DMD
9. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
10. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
11. Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , December 9, 2016 According to ... Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, ... to 2021" published by MarketsandMarkets, the global market is expected to ... 2016, at a CAGR of 10.6% during the forecast period. ... ...
(Date:12/8/2016)... Philadelphia, PA (PRWEB) , ... December 08, 2016 ... ... fan engagement platforms, the business of innovation is taking over sports. On Thursday, ... executive will explore how technology is disrupting the playing field at a Smart ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ability ... optogenetics — is key to exciting advances in the study and mapping of ... projected via free-space optics stimulates small, transparent organisms and excites neurons within superficial ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... bioInformatics portal. In response to client demand KbioBox developed a sophisticated “3 click” ... program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ and ...
Breaking Biology Technology:
(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... 2016 The report "Biometric Vehicle ... Technology (Iris Recognition System), Vehicle Type (Passenger Car, ... to 2021", published by MarketsandMarkets, the market is ... and is projected to grow to USD 854.8 ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
Breaking Biology News(10 mins):